Standout Papers

Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976 1993 2026 2004 2015 1.5k
  1. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976 (1993)
    Georg Martiny‐Baron, Marcelo G. Kazanietz et al. Journal of Biological Chemistry
  2. Protein kinase C isoenzymes: divergence in signal transduction? (1993)
    Hubert Hug, Thomas F. Sarre Biochemical Journal
  3. Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion? (1996)
    Susanne Strand, Walter Hofmann et al. Nature Medicine
  4. Involvement of an ICE-like protease in Fas-mediated apoptosis (1995)
    Masato Enari, Hubert Hug et al. Nature
  5. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. (1997)
    Martina Müller, Susanne Strand et al. Journal of Clinical Investigation

Immediate Impact

24 by Nobel laureates 53 from Science/Nature 122 standout
Sub-graph 1 of 14

Citing Papers

Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
19 intermediate papers

Works of Hubert Hug being referenced

Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?
1996 Standout
Different pathways mediate virus inducibility of the human IFN-α1 and IFN-β genes
1990
and 1 more

Author Peers

Author Last Decade Papers Cites
Hubert Hug 4818 1311 1518 42 6.7k
Beni B. Wolf 5231 1309 1200 52 7.5k
Masato Enari 7013 1244 1709 50 8.7k
Elizabeth Yang 5676 1554 1211 25 7.1k
Peng Li 5706 1045 1377 40 7.8k
George P. Livi 4459 1271 1232 51 6.3k
Cathy Tournier 4403 1101 990 58 6.1k
Jiping Zha 6184 1900 1147 42 8.1k
Ting-Ting Yamin 3959 943 1358 23 5.6k
Tak W. Mak 5525 1253 2266 44 8.0k
Dennis J. Templeton 5276 1607 1317 64 7.1k

All Works

Loading papers...

Rankless by CCL
2026